SAGE Therapeutics

SAGE Therapeutics is dedicated to the health and well being of patients with central nervous system (CNS) disorders. Their mission is to discover, develop and deliver novel medicines for many of today's most debilitating and disabling CNS disorders by leveraging compelling science, a robust clinical foundation, strong partnerships, and a world-class team of founders, advisors, investors, scientists and managers.

SAGE Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Therapeutics sector. The company focuses on Biotechnology and has secured $432.2B in funding across 160 round(s). With a team of 501-1000 employees, SAGE Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - SAGE Therapeutics, raised $35.0M. Discover more about their projects, partnerships, and impact on our platform.